DE3172028D1 - Pharmaceutical formulation - Google Patents

Pharmaceutical formulation

Info

Publication number
DE3172028D1
DE3172028D1 DE8181304086T DE3172028T DE3172028D1 DE 3172028 D1 DE3172028 D1 DE 3172028D1 DE 8181304086 T DE8181304086 T DE 8181304086T DE 3172028 T DE3172028 T DE 3172028T DE 3172028 D1 DE3172028 D1 DE 3172028D1
Authority
DE
Germany
Prior art keywords
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8181304086T
Other languages
English (en)
Inventor
Barry William Burnstead
David John Rooke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10516342&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3172028(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Application granted granted Critical
Publication of DE3172028D1 publication Critical patent/DE3172028D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8181304086T 1980-09-27 1981-09-08 Pharmaceutical formulation Expired DE3172028D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8031298 1980-09-27

Publications (1)

Publication Number Publication Date
DE3172028D1 true DE3172028D1 (en) 1985-10-03

Family

ID=10516342

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8181304086T Expired DE3172028D1 (en) 1980-09-27 1981-09-08 Pharmaceutical formulation

Country Status (15)

Country Link
US (1) US4537887A (de)
EP (1) EP0049061B1 (de)
JP (1) JPS5791921A (de)
AU (1) AU549321B2 (de)
CA (1) CA1187796A (de)
DE (1) DE3172028D1 (de)
ES (1) ES505803A0 (de)
GB (1) GB2084016B (de)
GR (1) GR75049B (de)
HK (1) HK17386A (de)
IE (1) IE51597B1 (de)
MY (1) MY8600353A (de)
NZ (1) NZ198241A (de)
PT (1) PT73686A (de)
ZA (1) ZA816272B (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3266580D1 (en) * 1981-12-02 1985-10-31 Beecham Group Plc Pharmaceutical formulation comprising beta-lactam antibiotics
JPS59104319A (ja) * 1982-12-06 1984-06-16 Chugai Pharmaceut Co Ltd 抗菌剤およびそのキツト
DE3887179T2 (de) * 1987-03-02 1994-06-16 Brocades Pharma Bv Pharmazeutische Zusammensetzung, pharmazeutisches Granulat und Verfahren zu ihrer Herstellung.
US5211958A (en) * 1987-11-30 1993-05-18 Gist-Brocades, N.V. Pharmaceutical composition and process for its preparation
ATE108996T1 (de) * 1988-02-25 1994-08-15 Brocades Pharma Bv Verfahren zur herstellung eines pharmazeutischen granulats.
US5643902A (en) * 1990-04-26 1997-07-01 Pfizer Inc. Veterinary treatment
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
GB9413542D0 (en) * 1994-07-05 1994-08-24 Smithkline Beecham Plc Pharmaceutical formulations
DE69523757T2 (de) * 1994-08-05 2002-08-01 West Pharm Serv Cornall Ltd Behälter für feuchtickeitsempfindliche stoffe und entsprechendes verfahren zum trocknen und zur reduktion
GB9416600D0 (en) * 1994-08-17 1994-10-12 Smithkline Beecham Plc Pharmaceutical formulation
DZ1926A1 (fr) * 1994-09-03 2002-02-17 Smithkline Beckman P L C Formulations pharmaceutiques.
ES2079327B1 (es) * 1994-12-13 1996-08-01 Lilly Sa Formulaciones farmaceuticas de cefaclor.
DZ2028A1 (fr) * 1995-05-03 2002-10-23 Smithkline Beecham Plc Médicaments destinés au traitement d'infections bactériennes en pédiatrie.
US20030109503A1 (en) * 1995-06-06 2003-06-12 Smithkline Beecham P.L.C. Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
KR100495585B1 (ko) * 1995-09-07 2005-09-09 스미스클라인비이참피이엘시이 제약 제제
ITMI952354A1 (it) * 1995-11-16 1997-05-16 Smithkline Beecham Spa Composizione farmaceutica
US5801796A (en) * 1996-05-10 1998-09-01 International Business Machines Corporation Stacked parallax-free liquid crystal display cell
GB9617780D0 (en) * 1996-08-24 1996-10-02 Smithkline Beecham Plc Method of treatment
ES2201468T3 (es) * 1997-02-14 2004-03-16 Laboratoire Glaxosmithkline S.A.S. Preparacion farmaceutica que comprende amoxicilina y clavulanato.
US20030124187A1 (en) * 1997-02-14 2003-07-03 Smithkline Beecham Laboratoires Pharmaceutiques, Pharmaceutical formulations comprising amoxycillin and clavulanate
US6296871B1 (en) * 1998-04-12 2001-10-02 Ranbaxy Laboratories Limited Stable solid pharmaceutical compositions containing enalapril maleate
US6177421B1 (en) 1999-05-04 2001-01-23 Fuisz International Ltd. Amoxicillin and clavulanate composition
IE990159A1 (en) * 1999-02-26 2000-09-20 Fuisz Internat Ltd Storage Stable Amoxycillin and Clavulanate Suspension Composition.
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
ATE319447T1 (de) * 1999-08-16 2006-03-15 Revaax Pharmaceuticals Llc Pharmazeutische zubereitungen die clavulansäure oder derivate enthalten zur behandlund von neurologischen störungen
US6426342B2 (en) * 1999-08-16 2002-07-30 Revaax Pharmaceuticals, Llc Use of β-lactamase inhibitors as neuroprotectants
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
AU2001292185A1 (en) 2000-10-12 2002-04-22 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
CA2359812C (en) * 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
KR100456833B1 (ko) * 2002-08-01 2004-11-10 주식회사 대웅 아목시실린 및 클라불라네이트를 함유하는 유핵정
EP1902708A1 (de) 2006-09-25 2008-03-26 Losan Pharma GmbH Wirkstoff enthaltende stabilisierte feste Arzneimittelformen und Verfahren zu ihrer Herstellung
AU2008317315A1 (en) * 2007-10-26 2009-04-30 Rexahn Pharmaceuticals, Inc. Pharmaceutical formulation of clavulanic acid
US20100255099A1 (en) * 2007-10-26 2010-10-07 Rexahn Pharmaceuticals, Inc. Clavulanate formulation for neuroprotection and treatment of neurodegenerative disorders
EA034234B1 (ru) 2013-03-15 2020-01-20 Брейнтри Лабораторис, Инк. Пероральные фармацевтические таблетированные композиции двойного применения, содержащие сульфат натрия или его комбинацию с другими сульфатными солями, и способы их получения и применения

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE888444C (de) * 1951-11-10 1953-08-31 Benckiser Gmbh Joh A Verfahren zum Tablettieren von hygroskopischen Praeparaten
US3432593A (en) * 1963-09-18 1969-03-11 Key Pharm Inc Delayed and sustained release type pharmaceutical preparation
GB1209634A (en) * 1967-06-29 1970-10-21 Rit Rech Ind Therapeut Stabilized antibiotic compositions for animal feeding and process for preparing them
DE2512247A1 (de) * 1975-03-20 1976-10-14 Thomae Gmbh Dr K Gegen feuchtigkeit stabilisierte presslinge mit feuchtigkeitsempfindlichen inhaltsstoffen
US4140755A (en) * 1976-02-13 1979-02-20 Hoffmann-La Roche Inc. Sustained release tablet formulations
JO984B1 (en) * 1977-10-11 1979-12-01 بيتشام غروب ليمتد A dry pharmaceutical compound with a suitable dosage unit for oral administration
IL58461A0 (en) * 1978-10-27 1980-01-31 Beecham Group Ltd Intramammary compositions comprising a clavulanic acid salt
US4226849A (en) * 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions

Also Published As

Publication number Publication date
ES8307095A1 (es) 1983-06-16
GR75049B (de) 1984-07-12
ES505803A0 (es) 1983-06-16
HK17386A (en) 1986-03-21
PT73686A (pt) 1981-10-01
CA1187796A (en) 1985-05-28
ZA816272B (en) 1982-09-29
AU7568481A (en) 1982-04-08
GB2084016B (en) 1985-04-17
MY8600353A (en) 1986-12-31
NZ198241A (en) 1983-12-16
JPH0155244B2 (de) 1989-11-22
EP0049061A1 (de) 1982-04-07
AU549321B2 (en) 1986-01-23
EP0049061B1 (de) 1985-08-28
IE51597B1 (en) 1987-01-21
US4537887A (en) 1985-08-27
JPS5791921A (en) 1982-06-08
IE812232L (en) 1982-03-27
GB2084016A (en) 1982-04-07

Similar Documents

Publication Publication Date Title
DE3172028D1 (en) Pharmaceutical formulation
ZA828797B (en) Pharmaceutical formulation
ZA813465B (en) Pharmaceutical composition
ZA814215B (en) Pharmaceutical preparations
DE3264782D1 (en) Medicinal formulation
MY8600312A (en) Pharmaceutical formulations
ZA81136B (en) Pharmaceutical compositions
GB2072504B (en) Pharmaceutical compositions
ZA815700B (en) Pharmaceutical compositions
GB2074028B (en) Pharmaceutical formulations
MTP884B (en) Pharmaceutical preparationes
ZA81650B (en) Pharmaceutical preparations
DE3176849D1 (en) Pharmaceutical composition comprising 4-carbamoyl-imidazolium-5-olate
HK90087A (en) Pharmaceutical formulation
PT73952A (en) Pharmaceutical compositions
ZA815175B (en) Pharmaceutical composition
AU543418B2 (en) Pharmaceutical formulation
KE3581A (en) Pharmaceutical formulation
IE822854L (en) Pharmaceutical formulation
DK173981A (da) Fremgangsmaade til fremstilling af cis-9-(3-(3,5-dimethyl-1-piperazinyl) propyl) carbazol eller salte deraf og mallemprodukter for fremstillingen
PT73810B (en) Pharmaceutical compositions
ZM8681A1 (en) Pharmaceutical compositions
ZA812902B (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
8364 No opposition during term of opposition